Study identity card

DELong#3

Italy
Share
  • Disease: Post-COVID-19
  • Study type: Randomised Clinical Trial
  • Study type descriptors: Interventional
  • Study aim: To evaluate the efficacy of VSL#3® compared to placebo in reducing fatigue in individuals with long COVID syndrome
  • Number of participants enrolled: Publication not available
  • Study enrolling from to
  • Study includes follow-up for 2 months

Study Data

  • Adults
  • Elderly
  • General population
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Probiotic

Other information

Funders:

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to